A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Clinical trial NCT06672575 · RECRUITING
Trial details
- NCT number
- NCT06672575
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2028-01-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.